HIS
CNCE

Harvest Investment Services’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Harvest Investment Services’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-42,122
Closed -$282K – 142
2022
Q3 		$282K Buy
+42,122
New +$255K 0.35% 91

Other funds holding CNCE

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harvest Investment Services's CNCE Position: Q4 2022 in Review

Harvest Investment Services sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2022, closing a stake of 42,122 shares — an estimated $282K sold.

Harvest Investment Services first reported a position in CNCE in Q3 2022 and held it in 1 quarter. The position peaked at $282K in Q3 2022. 85 funds tracked by Wall St. Rank hold CNCE as of Q4 2022.

  • Harvest Investment Services reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Harvest Investment Services sold 42,122 Concert Pharmaceuticals, Inc. shares in Q4 2022, an estimated $282K.
  • Harvest Investment Services first reported a position in Concert Pharmaceuticals, Inc. in Q3 2022 and held it in 1 quarter.
  • Harvest Investment Services's Concert Pharmaceuticals, Inc. position peaked at $282K in Q3 2022.
  • 85 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2022.

Based on Harvest Investment Services's 13F filing for Q4 2022, filed 14 Feb 2023.